Quantum Pharmaceutical is recalling three batches of diltiazem HCl 2% cream [unlicensed medicine]
The affected batches are:
|Product name||Batch number||Expiry date||Pack size||Date first distributed|
|Diltiazem HCl 2% Cream [unlicensed medicine]||M1402497||20 Sep 2023||30g||22 Jun 2023|
|Diltiazem HCl 2% Cream [unlicensed medicine]||M1402574||21 Sep 2023||30g||27 Jun 2023|
|Diltiazem HCl 2% Cream [unlicensed medicine]||M1402680||24 Sep 2023||30g||07 Jul 2023|
Affected products have a reduced viscosity and more closely resemble a lotion than a cream. These batches are being recalled as a precautionary measure.
Dispensaries are asked to quarantine all remaining stock and liaise with Quantum Pharmaceutical on the return process.
Patients using this product may experience issues with the application of the cream due to its consistency. However, this does not appear to have affected the product’s efficacy or pose a risk to patient safety. Affected patients should contact their dispenser for a replacement.
For medical information enquiries, email: [email protected]